<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:08:43Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/15458" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/15458</identifier><datestamp>2026-10-18T20:43:14Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>A comparative investigation of the analgesic effects of metamizole and paracetamol in rats</dc:title><dc:creator>Ince, Ilker</dc:creator><dc:creator>Aksoy, Mehmet</dc:creator><dc:creator>Ahiskalioglu, Ali</dc:creator><dc:creator>Comez, Mehmet</dc:creator><dc:creator>Dostbil, Aysenur</dc:creator><dc:creator>Celik, Mine</dc:creator><dc:creator>Yilmaz, Ismayil</dc:creator><dc:creator>Mammadov, Renad</dc:creator><dc:creator>Dogan, Hasan</dc:creator><dc:creator>Boztok Ozgermen, Basak</dc:creator><dc:creator>Altuner, Durdu</dc:creator><dc:subject>Analgesia</dc:subject><dc:subject>Carrageenan</dc:subject><dc:subject>Metamizole</dc:subject><dc:subject>Pain</dc:subject><dc:subject>Paracetamol</dc:subject><dc:subject>Rats</dc:subject><dc:subject>Acetaminophen</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Anti-Inflammatory Agents, Non-Steroidal</dc:subject><dc:subject>Cyclooxygenase 2</dc:subject><dc:subject>Dipyrone</dc:subject><dc:subject>Drug Evaluation, Preclinical</dc:subject><dc:subject>Glutathione</dc:subject><dc:subject>Male</dc:subject><dc:subject>Oxidative Stress</dc:subject><dc:subject>Pain, Postoperative</dc:subject><dc:subject>Peroxidase</dc:subject><dc:subject>Rats, Wistar</dc:subject><dc:subject>malonaldehyde</dc:subject><dc:subject>myeloperoxidase</dc:subject><dc:subject>nonsteroid antiinflammatory agent</dc:subject><dc:subject>algesimeter</dc:subject><dc:subject>analgesic activity</dc:subject><dc:subject>animal experiment</dc:subject><dc:subject>animal model</dc:subject><dc:subject>animal tissue</dc:subject><dc:subject>Article</dc:subject><dc:subject>controlled study</dc:subject><dc:subject>drug efficacy</dc:subject><dc:subject>gene expression</dc:subject><dc:description>Background: This study investigated the effects of metamizole and paracetamol on pain and oxidative stress induced by scalpel incision and carrageenan in rats. Materials and methods: Total of 144 rats were divided into groups of 12 animals. Six groups each were used for scalpel incision and carrageenan tests. Pain was inflicted by applying a scalpel incision or carrageenan. Pain-created groups by scalpel incision received metamizole (SIM) or paracetamol (SIP) at doses of 250 or 500 mg/kg. Pain-created groups by carrageenan received metamizole (CAM) or paracetamol (CAP) at doses of 250 or 500 mg/kg. Analgesic activity was determined by Basile Algesimeter. The COX-2 and MPO gene expressions were determined, and malondialdehyde and tGSH were measured in rat paws. Results: In the scalpel incision test, pain was reduced in groups of SIM-250 and SIM-500 in the first hour by 65.2% and 91.3%, respectively, and in the third hour by 51.9% and 77.8%, respectively, compared with the SIC group. In SIP-250 and SIP-500 groups, pain was reduced in the first hour by 43% and 74%, respectively, and by 33.4% and 59.3%, respectively, in the third hour compared with the SIC group. In the carrageenan test, in groups CAM-250 and CAM-500, pain was reduced in the first hour by 72.3% and 86.1%, respectively, and by 65.8% and 71.4%, respectively, in the third hour compared with the CCG group. In groups CAP-250 and CAP-500, pain was reduced in the first hour by 52.8% and 69.4%, respectively, and by 28.6% and 25.8%, respectively, in the third hour compared with the CCG group. Metamizole inhibited COX-2 gene expression at a dose of 500 mg/kg in the carrageenan test. At doses of 250 and 500 mg/kg, metamizole reduced COX-2 and MPO gene expressions and oxidative stress induced by scalpel incision or carrageenan. But both doses of paracetamol were unable to suppress that parameters. Conclusions: Our results show that metamizole is more effective than paracetamol for treating surgical trauma-related pain, inflammation, and oxidative stress and hence may be a preferential drug to paracetamol. © 2015 Informa Healthcare USA, Inc.</dc:description><dc:publisher>Informa Healthcare</dc:publisher><dc:date>2015</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/15458</dc:identifier><dc:identifier>https://doi.org/10.3109/08941939.2014.998798</dc:identifier><dc:identifier>0894-1939</dc:identifier><dc:language>en</dc:language><dc:relation>Journal of Investigative Surgery</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/15458</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>